ES8701230A1 - Procedimiento de producir preparaciones para tratar pacien- tes de hemofilia a inhibidores - Google Patents
Procedimiento de producir preparaciones para tratar pacien- tes de hemofilia a inhibidoresInfo
- Publication number
- ES8701230A1 ES8701230A1 ES549115A ES549115A ES8701230A1 ES 8701230 A1 ES8701230 A1 ES 8701230A1 ES 549115 A ES549115 A ES 549115A ES 549115 A ES549115 A ES 549115A ES 8701230 A1 ES8701230 A1 ES 8701230A1
- Authority
- ES
- Spain
- Prior art keywords
- viii
- inhibitor
- preparation
- treatment
- cag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003112 inhibitor Substances 0.000 title abstract 6
- 238000002360 preparation method Methods 0.000 title abstract 4
- 208000009292 Hemophilia A Diseases 0.000 title abstract 3
- 208000031220 Hemophilia Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 108010054218 Factor VIII Proteins 0.000 abstract 4
- 102000001690 Factor VIII Human genes 0.000 abstract 4
- 229960000301 factor viii Drugs 0.000 abstract 4
- 239000012634 fragment Substances 0.000 abstract 4
- 230000000694 effects Effects 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102100026735 Coagulation factor VIII Human genes 0.000 abstract 2
- 201000003542 Factor VIII deficiency Diseases 0.000 abstract 2
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000001042 affinity chromatography Methods 0.000 abstract 1
- 238000005341 cation exchange Methods 0.000 abstract 1
- 230000015271 coagulation Effects 0.000 abstract 1
- 238000005345 coagulation Methods 0.000 abstract 1
- 238000001962 electrophoresis Methods 0.000 abstract 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 abstract 1
- 230000006058 immune tolerance Effects 0.000 abstract 1
- 239000003547 immunosorbent Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 230000002947 procoagulating effect Effects 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
PROCEDIMIENTO DE PRODUCCION DE PREPARACIONES PARA EL TRATAMIENTO DE PACIENTES DE HEMOFILIA A INHIBIDORES, QUE CONTIENEN UNA PROTEINA O PEPTIDO CON ACTIVIDAD DE FACTOR VIII:CAG ESPECIFICA DE AL MENOS 0,5 U/MG DE PROTEINA, SIENDO LA RELACION ENTRE LA ACTIVIDAD DE FACTOR VIII:CAG Y LA ACTIVIDAD PROCOAGULANTE DE FACTOR VIII:C SUPERIOR A 5:1 Y PREFERIBLEMENTE A 10:1. CONSISTE EN TRATAR UNA SOLUCION QUE CONTIENE FACTOR VIII:CAG CON UN INMUNOABSORBENTE QUE CONTIENE ANTICUERPOS ESPECIFICOS AL FECTOR VIII:CAG LIGADO A PARTICULAS SOLIDAS Y LUEGO DISOLVER EL VIII:CAG LIGADO POR ELUCION CON UNA SOLUCION TAMPON, Y ELABORARLO EN UNA PREPARACION POR SECADO, DIALISIS, FILTRACION DE GEL O INTERCAMBIO IONICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK525384A DK525384D0 (da) | 1984-11-05 | 1984-11-05 | Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8701230A1 true ES8701230A1 (es) | 1986-12-01 |
ES549115A0 ES549115A0 (es) | 1986-12-01 |
Family
ID=8140859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES549115A Expired ES8701230A1 (es) | 1984-11-05 | 1985-11-05 | Procedimiento de producir preparaciones para tratar pacien- tes de hemofilia a inhibidores |
Country Status (11)
Country | Link |
---|---|
US (1) | US4831119A (es) |
EP (1) | EP0201574B1 (es) |
JP (1) | JPH0713026B2 (es) |
AT (1) | ATE69727T1 (es) |
AU (1) | AU599310B2 (es) |
CA (1) | CA1269042A (es) |
DE (1) | DE3584775D1 (es) |
DK (1) | DK525384D0 (es) |
ES (1) | ES8701230A1 (es) |
IL (1) | IL76929A (es) |
WO (1) | WO1986002838A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4508709A (en) * | 1983-12-05 | 1985-04-02 | Armour Pharmaceutical Company | Process for purifying factor VIII:C |
EP0251843A1 (fr) * | 1986-06-06 | 1988-01-07 | Transgene S.A. | Procédé de préparation de facteur VIII à partir de cellules de mammifères |
AU2473388A (en) * | 1987-11-16 | 1989-06-22 | Scripps Clinic And Research Foundation | Treatment of factor viii inhibitors |
EP0477302B1 (en) * | 1989-06-15 | 1995-02-01 | SMITH, William I. Jr. | Apparatus for inactivating infectious agents in and resisting coagulation of biological fluids |
DE69034042T2 (de) * | 1989-08-02 | 2003-07-17 | Mitra Medical Technology Ab Lu | System zur verwendung in einem verfahren zur therapeutischen und diagnostischen behandlung |
DK162233C (da) * | 1989-11-09 | 1992-03-16 | Novo Nordisk As | Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii |
IT1256622B (it) * | 1992-12-04 | 1995-12-12 | Sclavo Spa | Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale. |
AU7254894A (en) * | 1993-07-23 | 1995-02-20 | Baxter International Inc. | Activated human factor viii and method of preparation |
US5576291A (en) * | 1993-09-13 | 1996-11-19 | Baxter International Inc. | Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency |
PL365290A1 (en) * | 2001-02-05 | 2004-12-27 | Novo Nordisk Health Care Ag | Combined use of factor vii polypeptides and factor ix polypeptides |
EP1596887B1 (en) * | 2003-02-26 | 2022-03-23 | Nektar Therapeutics | Polymer-factor viii moiety conjugates |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
DE602004031390D1 (de) * | 2003-05-06 | 2011-03-24 | Syntonix Pharmaceuticals Inc | Gerinnungsfaktor VII-Fc chimäre Proteine zur Behandlung von hämostatischen Krankheiten |
WO2006003183A1 (de) * | 2004-07-02 | 2006-01-12 | Alois Jungbauer | Peptide zur blockierung von fviii-inhibitoren |
EP2968498A4 (en) | 2013-03-15 | 2016-09-07 | Biogen Ma Inc | PREPARATIONS CONTAINING FACTOR IX POLYPEPTIDE |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE448945B (sv) * | 1979-12-20 | 1987-03-30 | Blombaeck E G B | Forfarande for rening och /eller koncentrering av faktor viii-komplexet |
US4361509A (en) * | 1981-12-14 | 1982-11-30 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
AU555305B2 (en) * | 1982-09-29 | 1986-09-18 | Bayer Corporation | Antihemophilic factor concentrate |
US4406886A (en) * | 1983-01-14 | 1983-09-27 | University Patents, Inc. | Purification of antihemophilia factor VIII by precipitation with zinc ions |
US4649132A (en) * | 1983-03-31 | 1987-03-10 | Scripps Clinic And Research Foundation | Treatment of Factor VIII inhibitors |
DE3481109D1 (de) * | 1983-05-09 | 1990-03-01 | Novo Nordisk As | Antihaemophilie-faktor-viii-konzentrat und dessen herstellungsverfahren. |
GB8403473D0 (en) * | 1984-02-09 | 1984-03-14 | Special Trustees For St Thomas | Purification of factor viii |
FI852866L (fi) * | 1984-07-27 | 1986-01-28 | Meloy Lab | Rekombinantfaktor viii-r. |
-
1984
- 1984-11-05 DK DK525384A patent/DK525384D0/da unknown
-
1985
- 1985-11-04 CA CA000494555A patent/CA1269042A/en not_active Expired - Fee Related
- 1985-11-04 IL IL76929A patent/IL76929A/xx not_active IP Right Cessation
- 1985-11-05 EP EP85905784A patent/EP0201574B1/en not_active Expired - Lifetime
- 1985-11-05 US US06/881,687 patent/US4831119A/en not_active Expired - Lifetime
- 1985-11-05 AU AU50926/85A patent/AU599310B2/en not_active Ceased
- 1985-11-05 DE DE8585905784T patent/DE3584775D1/de not_active Expired - Fee Related
- 1985-11-05 ES ES549115A patent/ES8701230A1/es not_active Expired
- 1985-11-05 WO PCT/DK1985/000105 patent/WO1986002838A1/en active IP Right Grant
- 1985-11-05 AT AT85905784T patent/ATE69727T1/de not_active IP Right Cessation
- 1985-11-05 JP JP60505194A patent/JPH0713026B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4831119A (en) | 1989-05-16 |
EP0201574B1 (en) | 1991-11-27 |
DE3584775D1 (de) | 1992-01-09 |
ATE69727T1 (de) | 1991-12-15 |
IL76929A (en) | 1990-07-26 |
ES549115A0 (es) | 1986-12-01 |
EP0201574A1 (en) | 1986-11-20 |
WO1986002838A1 (en) | 1986-05-22 |
AU599310B2 (en) | 1990-07-19 |
JPH0713026B2 (ja) | 1995-02-15 |
DK525384D0 (da) | 1984-11-05 |
AU5092685A (en) | 1986-06-03 |
JPS62501006A (ja) | 1987-04-23 |
IL76929A0 (en) | 1986-04-29 |
CA1269042A (en) | 1990-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8701230A1 (es) | Procedimiento de producir preparaciones para tratar pacien- tes de hemofilia a inhibidores | |
US4877614A (en) | Biologically active fragments of human antihemophilic factor and method for preparation thereof | |
RU95115239A (ru) | Аналог эритропоэтина | |
EP2145897A3 (en) | Therapeutic methods and compositions based on serrate proteins and nucleic acids | |
CA2032153A1 (fr) | Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant | |
MX9703643A (es) | Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana. | |
WO1994011503A3 (en) | Chimeric factor viii | |
AU3068289A (en) | Chromatographic separation of plasma proteins | |
DE68916932D1 (de) | Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus. | |
AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
CA2248960A1 (en) | Stable factor viii/vwf-complex | |
WO1996028470A3 (en) | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis | |
IL84700A (en) | Hybrid proteins,dnas coding therefor,hybrid vectors containing such dnas and hosts transformed therewith,the preparation of such hybrid proteins and pharmaceutical compositions containing them | |
Stathakis et al. | Human fibrinogen heterogeneities. Preparation and characterization of γ and γ′ chains | |
HUT50195A (en) | New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions | |
Guisasola et al. | Plasmin digestion of factor VIII: characterization of the breakdown products with respect to antigenicity and von Willebrand activity | |
Ferguson et al. | Localization of the disulfide bond in human antithrombin III required for heparin-accelerated thrombin inactivation | |
AU3595489A (en) | Amblyommin, a new active substance for anticoagulant therapy | |
DOOLITTLE et al. | Synthetic peptide probes and the location of fibrin polymerization sites | |
NO991653L (no) | Immunogenisk tumor frigjorte partikler (TLP)-blanding | |
Araujo et al. | Potentiation of bradykinin action on smooth muscle by a scorpion venom extract | |
Montgomery et al. | The carbohydrate-protein linkage in ovomucoid | |
EP0675135A2 (en) | Protein PHBP-70, having heparin binding and fibroblast proliferating properties | |
Smith et al. | Ultrastructural studies of the human complement components C3 and factor B and of cobra venom factor (CVF) |